Kenya's Vaccine Manufacturing Push Signals a New Chapter for Africa's Health Sovereignty

Africa's ambition to build pharmaceutical self-sufficiency has received another significant boost. Japan has committed KSh3 billion (approximately US$23 million) to support Kenya's vaccine manufacturing programme, reinforcing Nairobi's long-term goal of producing vaccines domestically by 2027. While the announcement centres on funding for research infrastructure, regulatory cooperation and scientific capacity, its significance extends far beyond Kenya's borders.

Raccontata daiol.co.za